missing translation for 'onlineSavingsMsg'
Learn More
Learn More
MAPK8 (JNK1) rekombinantes humanes Protein
MAPK8 (JNK1), rekombinantes, humanes Protein
Marke: Invitrogen PV3319
Weitere Details : Netto-Gewicht : 3.36000kg
Beschreibung
MAPK8 (JNK1) wird durch das Vorhandensein von missgebildeten Proteinen im endoplasmatischen Retikulum aktiviert. Es ist auch ein entscheidender Vermittler von Insulinresistenz und Adipositas.Spezifikation
| NP_002741.1 | |
| Storage Buffer: 50mM Tris, pH 7.5, 150mM NaCl, 0.05mM EDTA, 0.05% Triton X-100, 2mM DTT, 50% glycerol Store at -80°C. At first use, aliquot and store at -80°C to avoid multiple freeze-thaws. |
|
| Dry Ice | |
| MAPK8 | |
| Baculovirus | |
| Full Length, Recombinant | |
| Signal Transduction | |
| Kinase Assay | |
| 47.6 kDa | |
| MAPK8 (JNK1) | |
| His Tag |
| Biochemical phospho-specific activity (no antibody), Biochemical terbium phospho-specific activity, Biochemical binding/kinetic | |
| Ser⁄Thr Kinases: CMGC Group | |
| LanthaScreen® Antibody, LanthaScreen® Substrate, Z'-LYTE™, Omnia® Bulk Substrate | |
| mitogen-activated protein kinase 8 | |
| Kinases & Inhibitors | |
| Serine⁄Threonine Kinases | |
| Human | |
| 5599 | |
| 10 μ g | |
| MAP Kinase Family |
Nur für Forschungszwecke. Nicht zur Verwendung bei diagnostischen Verfahren.